Sites

Our experts answered some of the most popular questions from "Racial Diversity in Clinical Trials: Building Trust in Participant Engagement."

On October 22, 2020, the FDA's VRBPAC met to discuss the development, authorization, and licensure of vaccines to prevent COVID-19.

Daniel Eisenman answers questions from his latest webinar Study Startup Success for the New Generation of Genetically Engineered Vaccines.

In investigator-initiated trials, an investigator takes on the clinical study as both the sponsor and investigator. Learn more about IITs impact on the clinical research industry.

New California regulations apply to companies who have information about CA residents regardless of where the company is located. Read more:

How has the COVID-19 pandemic changed oncology research--and research in general? Read more for the follow-up blog to our recent symposium:

Learn more about how you can improve your clinical research data quality with these five fundamentals of clinical data management.

When using remote sites to perform clinical trial procedures, keep in mind things like whether remote sites are considered "engaged" in research. Read more:

Understanding what auditors look for and why when conducting SDV and SDR will help ensure your next site audit goes well. Read more:

COVID-19 complicates traditional models of community consultation. How should sites conducting planned emergency research approach community consultation?

Innovations in oncology have sparked advancements in the clinical trial industry and empowered COVID-19 research. Read more:

Gain a better understanding of clinical trial budget negotiations to reduce delays and study startup times.